110 related articles for article (PubMed ID: 22508529)
1. Strongly enhanced levels of sclerostin during human fracture healing.
Sarahrudi K; Thomas A; Albrecht C; Aharinejad S
J Orthop Res; 2012 Oct; 30(10):1549-55. PubMed ID: 22508529
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of macrophage colony-stimulating factor in human fracture healing.
Sarahrudi K; Mousavi M; Thomas A; Eipeldauer S; Vécsei V; Pietschmann P; Aharinejad S
J Orthop Res; 2010 May; 28(5):671-6. PubMed ID: 19950360
[TBL] [Abstract][Full Text] [Related]
3. VEGF serum concentrations in patients with long bone fractures: a comparison between impaired and normal fracture healing.
Sarahrudi K; Thomas A; Braunsteiner T; Wolf H; Vécsei V; Aharinejad S
J Orthop Res; 2009 Oct; 27(10):1293-7. PubMed ID: 19402151
[TBL] [Abstract][Full Text] [Related]
4. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta1 as a marker of delayed fracture healing.
Zimmermann G; Henle P; Küsswetter M; Moghaddam A; Wentzensen A; Richter W; Weiss S
Bone; 2005 May; 36(5):779-85. PubMed ID: 15811636
[TBL] [Abstract][Full Text] [Related]
6. The systemic angiogenic response during bone healing.
Weiss S; Zimmermann G; Pufe T; Varoga D; Henle P
Arch Orthop Trauma Surg; 2009 Jul; 129(7):989-97. PubMed ID: 19037648
[TBL] [Abstract][Full Text] [Related]
7. Is sonic Hedgehog involved in human fracture healing? --a prospective study on local and systemic concentrations of SHH.
Eipeldauer S; Thomas A; Hoechtl-Lee L; Kecht M; Binder H; Koettstorfer J; Gregori M; Sarahrudi K
PLoS One; 2014; 9(12):e114668. PubMed ID: 25501422
[TBL] [Abstract][Full Text] [Related]
8. Close negative correlation of local and circulating Dickkopf-1 and Sclerostin levels during human fracture healing.
Starlinger J; Santol J; Kaiser G; Sarahrudi K
Sci Rep; 2024 Mar; 14(1):6524. PubMed ID: 38499638
[TBL] [Abstract][Full Text] [Related]
9. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE
J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318
[TBL] [Abstract][Full Text] [Related]
10. Cigarette smoking decreases TGF-b1 serum concentrations after long bone fracture.
Moghaddam A; Weiss S; Wölfl CG; Schmeckenbecher K; Wentzensen A; Grützner PA; Zimmermann G
Injury; 2010 Oct; 41(10):1020-5. PubMed ID: 20471641
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of sclerostin and dickkopf-1: effects of age, gender and fracture status.
Dovjak P; Dorfer S; Föger-Samwald U; Kudlacek S; Marculescu R; Pietschmann P
Gerontology; 2014; 60(6):493-501. PubMed ID: 24943689
[TBL] [Abstract][Full Text] [Related]
12. Elevated concentrations of hypoxia-inducible factor-1α in patients with fracture and concomitant traumatic brain injury.
Sang X; Wang Z; Qin T; Li Y
Ann Clin Biochem; 2017 Sep; 54(5):584-592. PubMed ID: 27687082
[TBL] [Abstract][Full Text] [Related]
13. Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis.
Rossini M; Viapiana O; Zanotti R; Tripi G; Perbellini O; Idolazzi L; Bonifacio M; Adami S; Gatti D
Calcif Tissue Int; 2015 May; 96(5):410-6. PubMed ID: 25694360
[TBL] [Abstract][Full Text] [Related]
14. SOST is a target gene for PTH in bone.
Keller H; Kneissel M
Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.
Delgado-Calle J; Sañudo C; Bolado A; Fernández AF; Arozamena J; Pascual-Carra MA; Rodriguez-Rey JC; Fraga MF; Bonewald L; Riancho JA
J Bone Miner Res; 2012 Apr; 27(4):926-37. PubMed ID: 22162201
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model.
Yee CS; Xie L; Hatsell S; Hum N; Murugesh D; Economides AN; Loots GG; Collette NM
Bone; 2016 Jan; 82():122-34. PubMed ID: 25952969
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis.
Tsui FW; Tsui HW; Las Heras F; Pritzker KP; Inman RD
Ann Rheum Dis; 2014 Oct; 73(10):1873-9. PubMed ID: 23894062
[TBL] [Abstract][Full Text] [Related]
18. Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro.
Jäger A; Götz W; Lossdörfer S; Rath-Deschner B
J Periodontal Res; 2010 Apr; 45(2):246-54. PubMed ID: 19778325
[TBL] [Abstract][Full Text] [Related]
19. Systemic response of the GH/IGF-I axis in timely versus delayed fracture healing.
Weiss S; Henle P; Bidlingmaier M; Moghaddam A; Kasten P; Zimmermann G
Growth Horm IGF Res; 2008 Jun; 18(3):205-12. PubMed ID: 17936052
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin monoclonal antibodies on bone metabolism and fracture healing.
Gamie Z; Korres N; Leonidou A; Gray AC; Tsiridis E
Expert Opin Investig Drugs; 2012 Oct; 21(10):1523-34. PubMed ID: 22849579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
